
More shares, more Bitcoin, more debate
Strategy just did the thing again: it sold 1.73 million MSTR shares through its at-the-market program and used the $209 million haul to buy 1,587 more Bitcoin and add $100 million to its USD reserve. The result? More BTC on the balance sheet, a bigger cash cushion, and another round of investors asking, “Cool… but who’s paying for the dilution?”
The financing loop
The math here is very Strategy-coded:
- Buy Bitcoin without selling your Bitcoin stash
- Fund it with stock sales instead of operating cash flow
- Keep a reserve around to cover preferred dividends and interest
That reserve now sits at about $1.1 billion, which is less “rainy day fund” and more “we are absolutely committed to this trade.”
Why investors care
On one hand, the company is doubling down on its Bitcoin thesis while BTC is still doing the heavy lifting for the stock. On the other hand, every new share sold can chip away at per-share value for common holders. That’s the beef Peter Schiff is pounding on X: Strategy may be protecting the preferred stack and its Bitcoin position, but common shareholders are the ones taking the dilution hit.
The trade-off in plain English
If Bitcoin keeps ripping, this playbook looks genius. If it stalls, the structure starts to look a little like using one credit card to pay another while buying more lottery tickets. Big picture: Strategy is still the market’s most aggressive corporate Bitcoin proxy, but the stock is increasingly a referendum on whether you trust the balance-sheet sorcery more than you fear the dilution.
